|
|
Article: Amicus Therapeutics to Present at JPMorgan Healthcare Conference.
- Article from:
- PR Newswire
- Article date:
- January 4, 2006
|
Copyright informationCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CRANBURY, N.J., Jan. 4 /PRNewswire/ -- Amicus Therapeutics, a biopharmaceutical company developing small molecule, orally-active pharmacological chaperones for the treatment of human genetic diseases, today announced that the company will present at the 24th Annual JPMorgan Healthcare Conference. This will be the company's first public presentation since a new management team was put into place with the appointment of John F. Crowley as chairman and CEO in January 2005. The presentation will take place at 3 p.m. PT on Monday, January 9, 2006, at the Westin St. Francis Hotel in San Francisco.
Amicus Therapeutics is a clinical stage company pioneering a paradigm-shifting ...
Related newspaper, magazine, and journal articles:
|